Investment bank Jefferies & Co. announced today the expansion of its medical devices and diagnostics coverage, with the addition of managing director and senior equity research analyst Peter Bye. The former senior research analyst at Wachovia Securities brings roughly 10 years of industry experience to New York-based Jefferies. Most recently, at Wachovia, Bye covered small- and mid-cap medical technology companies. He’s held similar roles at Citigroup/Smith Barney, SG Cowen Securities, and Warburg Dillon Read. On the sector, Bye said in a company press release, “Medical devices and diagnostics companies garner significant investor interest and are an increasingly important area of healthcare in terms of ongoing advancements and their overall impact on the healthcare landscape.”